Videoconference telepsychiatry provides an alternative for the psychiatric treatment of mental health patients who reside in remote communities. The objective of this study was to compare institutional ambulatory and hospitalization costs, treatment adherence, patient and physician satisfaction, and treatment safety between mental healthcare via videoconferencing and care provided in person. Data collected for 1 year of telepsychiatry treatment was compared to that of the preceding year and a matched comparison group. Twenty-nine patients from Or Akiva and 20 patients from Reut Hostel in Hadera who met the inclusion criteria agreed to participate; 24 and 15 patients, respectively, completed the study. Forty-two matched patients, who continued face-to-face interviews, comprised the comparison group. Drop-out patients and those who did not consent to telepsychiatry treatment were not involved. During the year of telepsychiatry treatment, patients and physicians were satisfied and treatment was safe. However, 1 hour of telepsychiatry treatment was more expensive than face-to-face care, and a tendency of increased hospitalizations was noted. Adherence ratios before and during telepsychiatry treatment were similar, but were twice as high versus the comparison group. The limited sample size precludes the drawing of definite conclusions, and further studies involving a larger study population and longer duration of investigation is warranted.
INTRODUCTION N

EW TELECOMMUNICATION TECHNOLOGIES
have already influenced the spatial and temporal relationships between health professionals and patients. 1 Studies have shown that telepsychiatry offers a viable alternative for service delivery to patients who live in distant rural areas. 2 The 1980s introduced studies that included questionnaires for the evaluation of telepsychiatry 3 and more recent studies demonstrated patient and physician satisfaction. [4] [5] [6] In their systematic review of patient satisfaction with telehealth care Williams et al. 7 reported levels of satisfaction greater than 80% and frequent reports of 100% satisfaction. Studies from the late 1990s found that diagnosis and treatment via telepsychiatry was as reliable and efficient as face-to-face interviews, with high interrater reliability in the diagnosis of people suffering from obsessive-compulsive disorder, 8 anxiety and depressive disorders, 1 schizophrenia, 9 and paranoid schizophrenia with no exacerbation of delusional symptoms. 3 Telepsychiatry has also been successfully used for treatment of posttraumatic stress disorder 10 and for the treatment of depression. 11 More recent studies placed the emphasis on actual geographic distance between the examiners and the patients and found that patients expressed equal satisfaction and ability to develop a relationship in both in-person and telepsychiatric interviews. 1, 12 Since 1960, the use of telepsychiatry has proven beneficial in solving the problem of lack of adequate psychiatric services in remote communities. Many projects of telepsychiatric services have been described in the literature. The most expansive project was undertaken in southern Australia, and began in 1994. 13 Telepsychiatry was implemented to provide a solution for a broad spectrum of psychiatric services for community-based clients scattered across 1 million square kilometers. More than 2,000 consultations-emergency services and liaison services for inpatients, and follow-up visits were administered during the first 4 years of the project.
Freuh et al. 14 conducted a survey of telepsychiatry that dealt mainly with administration of psychiatric services in geographically distant communities and reported a lack of empirical studies of telepsychiatry (i.e., clinical outcome studies and cost analysis). In a comprehensive systematic review of the literature of the assessment of telemedicine, Roine et al. 15 concluded that while relatively convincing evidence of effectiveness was found for telepsychiatry, evidence regarding the effectiveness and cost-effectiveness of telemedicine is still limited.
We opened the first two satellite videoconference telepsychiatry (VCTP) clinics in Israel, in Or Akiva (OA) and Hadera (Hd), located 20 and 15 km, respectively, from the ShaarMenashe Mental Health Center (SMMHC) ambulatory clinic. Prior to the study, the treating psychiatrist traveled to Hd to see patients. OA patients came to the ambulatory clinic at SMMHC. Transportation costs and travel-associated hardships of OA patients account in part for the occasional difficulties in adherence to follow-up care.
We sought to evaluate the cost of ambulatory care and hospitalization, treatment adherence, clinical safety, and patients' and therapists' satisfaction in two VCTP settings in comparison to face-to-face care.
MATERIALS AND METHODS
Subjects
Patients were over 18 years of age, spoke Hebrew, and had at least 1-year of face-to-face treatment before the initiation of the study. One hundred four patients from the towns of OA and Reut Hostel in Hd sought help from SMMHC ambulatory clinic during the trial period. Twenty-nine patients from OA and 20 patients from Reut Hostel in Hd who met the inclusion criteria agreed to replace face-to-face interviews with VCTP and participated in the study; 24 and 15 patients, respectively, completed the study. Forty-two matched patients who did not participate in VCTP treatment comprised the comparison group. Five patients from OA and 5 from Hd dropped out. In OA, 2 withdrew consent, 2 relocated, and 1 discontinued after hospitalization. In Hd, 1 patient committed suicide while hospitalized in a general hospital and 4 relocated. Patients who did not meet inclusion criteria for participation in the study and patients who dropped out from VCTP treatment were not included in the analyses. All participants met International Statistical Classification of Diseases and Related Health Problems (ICD-10) diagnostic criteria for major psychiatric disorders. The Institutional Review Board (IRB) of SMMHC approved the study. The participants retained the option to return to face-to-face care.
Demographics of the VCTP and comparison groups are presented in Table 1 . The groups matched for age, gender, education, family status, and diagnoses. The social counselor from OA and the social worker from Reut Hostel who served as case managers accompanied the patients during their sessions.
Instruments
Safety was monitored using the Brief Psychiatric Rating Scale (BPRS) 16 and the Clinical Global Impression Scale (CGI) 17 at baseline and every 3 months thereafter.
Satisfaction was measured at the 3-, 6-, 9-, and 12-month visits using the Patient Satisfaction Questionnaire (PSQ)-completed by patients and Therapist Satisfaction Questionnaire (TSQ)-completed by therapists, modifications of the Missouri Telehealth Network 18 satisfaction questionnaire. Answers for both questionnaires ranged from 1, (not satisfied) to 5 (extremely satisfied). The PSQ included the following items: general impression, the ability to contact the therapist, the ability of the therapist to diagnose, feeling of comfort, the level of discomfort and nervousness, accessibility, the quality of treatment, similarity to face-toface interview, the quality of equipment, willingness to use again and the sense of therapist's presence. TSQ included similar items aside from "the sense of comfort" and "nervous- 
Statistical analyses
Analysis of variance ANOVA with repeated measures was used for the comparison of BPRS, CGI, and satisfaction questionnaires, two-tailed t test was used to compare duration of hospitalizations. The adherence ratio was the mean number of visits/mean number of missed visits. t Test or 2 was used for the comparison of demographic data. Tables 2, 3 , and 4. Adherence ratios were twice as high in the VCTP group as in the comparison group but similar within the groups. Mean hospitalization days were not significantly increased ( Average institutional costs for hospitalization were 223.7% higher during VCTP treatment and 132.5% during the parallel periods of the matched comparison groups. The costs of an hour-long session were 32% higher during VCTP treatment. When travel expenses of OA patients for the year preceding VCTP were included in calculations, VCTP hour costs were higher by only 10.6%.
RESULTS
Results are presented in
As expected, patients and therapists were generally satisfied (df ϭ 3,172; F ϭ 9.38, p Ͻ 0.0001; df ϭ 3,172; F ϭ 12.69, p Ͻ 0.0001, respectively). All PSQ final scores significantly improved (p Ͻ 0.05) and were above 4 except treatment quality (df ϭ 3,172; F ϭ 2.69, p Ͼ 0.05), satisfaction with equipment (df ϭ 3,172; F ϭ 0.74, p Ͼ 0.05) and nervousness (df ϭ 3,172; F ϭ 1.47, p Ͼ 0.05), which remained stable. In addition, all TSQ final scores were above 4 and significantly improved during the study (df ϭ 3,172; p Ͻ 0.0001). The sense of presence during interview, an item not generally included in satisfaction scales also showed significant improvement in patients' and therapists' evaluations during the study (df ϭ 3,172; F ϭ 5.81, p Ͻ 0.001; df ϭ 3,172; F ϭ 15.93, p Ͻ 0.0001, respectively).
As presented in Table 4 , VCTP treatment was clinically safe; BPRS scores significantly decreased during the study and CGI scores remained stable.
DISCUSSION
Institutional costs (hospitalizations and sessions) are higher during VCTP. Ruskin et al. 11 found that the cost of remote treatment was equal to that of in-person treatment if the psychiatrist had to travel 35.2 km. In a more distant facility, VCTP treatment was even less expensive than in-person treatment. In the present study, the distance between the main clinic and satellites was less than 35.2 km (15 to 20 km), nevertheless, costs during VCTP treatment were increased most probably as a result of the fact that travel expenses affected the therapist in Hd and the patients in OA.
Hospitalization rates and costs increased (not significantly) during VCTP treatment and in the parallel periods within the comparison group. Because only a few patients were hospitalized and the study groups were relatively small, results were statistically not significant and should be considered with caution.
Adherence ratios were twice as high in the VCTP group as a whole than those of the comparison group but did not change within groups. The differences in adherence ratios between VCTP and comparison groups might arise from methodology; it might be that the compliance of those patients who agreed to participate in VCTP was better than those who refused.
VCTP in the treatment of major psychiatric disorders is known to be safe and both therapists and patients have expressed satisfaction. 1, [4] [5] [6] 9, 11, 12 Ruskin et al. 11 reported that telepsychiatry was effective in the ambulatory treatment of 119 depressed outpatients as measured by depression, anxiety, global, clinical and health scales. Medication adherence and patient satisfaction were also positive.
In the present study, both therapists and patients experienced "presence," a fact that may account for the ability to establish positive relationships between them, 1, 12 and overcome detachment that might be created while speaking to a faceless electronic device.
Two unique phenomena associated with VCTP sessions were observed. First, patients were more meticulous about their appearance, and second, the interviews were more organized, with patient and doctor more courteous in that they did not interrupt one another.
This study had several limitations. The fact that the comparison group included patients that did not consent to VCTP treatment might account for inherent differences between the comparison and the VCTP groups. The small number of hospitalized patients and study groups might account for the statistically insignificant differences in hospitalization days between the investigated groups. The cost analysis is limited to the presented procedures; outreach and in-person clinics, items included in calculations, and the setting of a governmental institution, and might differ when other procedures or psychiatric settings such as private institutions are evaluated.
CONCLUSION
Patients and physicians are satisfied with VCTP, treatment is safe and effective, and adherence to treatment remains stable. However, operational costs of VCTP may be higher than face-to-face care, and a tendency of increased hospitalization costs was noted. The limited sample size precludes the drawing of definite conclusions, and further studies involving a larger study population and longer duration of investigation is warranted.
